Taking people in Franciaország1. fázis
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Key facts
- Where
- Lyon, Marseille, Toulouse és Vandoeuvre Les Nancy Cedex, FranciaországSee the 4 sites
- Phase
- 1. fázis
Where in Franciaország
- Centre Leon BerardLyon, FranciaországTaking people
- Institut Paoli-CalmettesMarseille, FranciaországTaking people
- Oncopole Claudius RegaudToulouse, FranciaországTaking people
- CHRU De NancyVandoeuvre Les Nancy Cedex, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Novartis Pharma AG
- Trial code
- EU 2025-521702-18-00
- Record updated
- 2026. szeptember 15.